What clinical evidence supports using GLP-1 drugs with bupropion for weight loss
Bachelez H, van de Kerkhof PC, Strohal R, Kubanov A, Valenzuela F, Lee JH,
Second, the head-to-head comparison (SGLT2i vs GLP1-RA) shows no material difference in VTE risk (pooled HR 1.02), with the most imprecise estimate contributed by the small GLP1-RA cohort in Tsai and therefore carrying minimal meta-analytic weight [22, 24, 25]
Your prescriber may delay increases if you are experiencing side effects or achieving good results at a lower dose
It is counterintuitive, but one of the cleaner randomized Alzheimers trials found exactly that: a 10 mL daily dose improved both cognition and global function, while higher 30 and 60 mL doses helped global function but not cognition, a reversed-U pattern where more was not better